Barclays Announces Senior Secured Credit Facilities Financing for Acquisition by Albany Molecular Research Inc.

July 17, 2015

New York, NY— Paul Hastings LLP, a leading global law firm, announced today that the firm advised Barclays Bank PLC as administrative agent and lead arranger for $230 million of senior secured credit facilities, consisting of a $200 million first lien term loan and a $30 million revolving credit facility, of Albany Molecular Research, Inc., a leading global contract researcher and manufacturer of pharmaceutical and drug products. The proceeds of the term loan were used by the borrower, among other things, to partially finance its acquisition of GADEA GRUPO FARMACÉUTICO, S.L., a Spanish-based developer and manufacturer of active pharmaceutical ingredients and related drug products and to repay its existing revolving credit facility.

Leveraged Finance partner John Cobb led the Paul Hastings team, which also included of counsel Benjamin Cheng and associates Joseph Fastiggi, Julie Park and Sean Murray.

Paul Hastings LLP is a leading global law firm with offices in Asia, Europe, and the United States. We provide innovative legal solutions to financial institutions and Fortune 500 companies. Please visit www.paulhastings.com for more information.